Formation of isoprostanes in children with type IIa hypercholesterolemia

J Cardiovasc Pharmacol. 2001 Aug;38(2):228-31. doi: 10.1097/00005344-200108000-00008.

Abstract

F2-isoprostanes are stable lipid peroxidation products of arachidonic acid and their quantification provides a novel approach to the assessment of oxidative stress in vivo. F2-isoprostanes are present in increased amounts in adult hypercholesterolemia, but no data exist concerning children. We investigated urinary isoprostaglandin F2, type III production as an index of lipid peroxidation in 15 children presenting with type IIa hypercholesterolemia (serum total cholesterol, 290 [SD +/- 70] mg/dl; low-density lipoprotein cholesterol, 210 [SD +/- 90] mg/dl) compared with 15 sex- and age-paired control children (serum total cholesterol, 160 [SD +/- 20] mg/dl). Urinary levels of isoprostaglandin F2alpha type III were measured by gas chromatography mass spectrometry. Urinary concentrations did not differ significantly in hypercholesterolemic children compared with control children (84.7 [SD +/- 37] vs. 96 [SD +/- 35] pmol/mmol creatinine, respectively). No significant correlation was found with total cholesterol, low-density-lipoprotein and high-density-lipoprotein cholesterol, and apolipoprotein B and A1 serum levels. F2-isoprostane urinary levels in children with type IIa hypercholesterolemia do not differ from those of age- and sex-matched control children and are not correlated to blood lipid parameters, suggesting that hypercholesterolemia is not associated with increased lipid peroxidation in childhood.

Publication types

  • Comparative Study

MeSH terms

  • Adolescent
  • Biomarkers / urine
  • Child
  • Female
  • Humans
  • Hyperlipoproteinemia Type II / metabolism*
  • Hyperlipoproteinemia Type II / urine
  • Isoprostanes / metabolism*
  • Isoprostanes / urine
  • Lipid Peroxidation
  • Male
  • Statistics, Nonparametric

Substances

  • Biomarkers
  • Isoprostanes
  • isoprostane F2alpha III